Why Merck’s Covid-19 pill molnupiravir could be so important →
The pharma giant said its new antiviral drug cut hospitalisations in half for at-risk Covid-19 patients. VOX
The pharma giant said its new antiviral drug cut hospitalisations in half for at-risk Covid-19 patients. VOX